- Citado por SciELO
- Citado por Google
- Similares em SciELO
- Similares em Google
versão impressa ISSN 0037-8682
Rev. Soc. Bras. Med. Trop. vol.44 no.3 Uberaba maio/jun. 2011
CASE REPORT RELATO DE CASO
Febre maculosa brasileira sem exantema causada por Rickettsia rickettsii em um paciente de cor negra
Alexsandra Rodrigues de Mendonça FavachoI; Tatiana RozentalI; Simone Berger CalicII; Maria Aparecida Mota ScofieldIII; Elba Regina Sampaio de LemosI
ILaboratório de Hantaviroses e Rickettsioses, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, RJ
IIDivisão de Epidemiologia e Controle de Doença, Instituto Octávio Magalhães, Fundação Ezequiel Dias, Belo Horizonte, MG
IIISecretaria Municipal de Saúde de Itambacuri, Itambacuri, MG
Brazilian spotted fever (BSF) is the most important and frequent rickettsial disease in Brazil. A fatal case of BSF is reported in a 32-year-old black man, who died of irreversible shock after five days of fever, severe headache and abdominal pain with no rash. Spleen, kidney and heart samples collected at autopsy were positive for Rickettsia rickettsii by PCR and sequencing. The authors emphasize the need for a high index of diagnostic suspicion for spotted fever in black patients. Absence of a skin rash should not dissuade clinicians from considering the possibility of BSF and initiating empirical therapy.
Keywords: Fatal Brazilian spotless fever. Black patient. PCR.
Febre maculosa brasileira (FMB) é a mais importante e frequente doença rickettsial no Brasil. Relatamos um caso fatal de FMB em um homem negro de 32 anos de idade que morreu de choque irreversível após cinco dias de febre, cefaléia intensa, dor abdominal, e sem evidência de exantema. Amostras de baço, rim e coração coletadas na necropsia foram positivas para Rickettsia rickettsii por PCR e sequenciamento. Os autores ressaltam a necessidade de um alto índice de suspeita diagnóstica para febre maculosa em pacientes negros. Ausência de exantema não deve dissuadir os clínicos de considerar a possibilidade de FMB e iniciar a terapêutica empírica.
Palavras-chaves: Febre maculosa brasileira sem exantema. Paciente negro. PCR.
Described for the first time in 1929, Brazilian spotted fever (BSF) is caused by Rickettsia rickettsii and is considered the most important spotted fever group rickettsiosis (SFGR) in Brazil1-6. Since 2001, when national compulsory notification was implemented, the number of notified BSF cases has increased and in the last 10 years, more than 735 confirmed cases have been reported, with a mean mortality of 28% (Brazilian Ministry of Health, 2009). Although the clinical triad of fever, headache and rash is considered the classical description of BSF, which is similar to Rocky Mountain spotted fever (RMSF), this infection has a broader spectrum of manifestations, ranging from asymptomatic and mild disease to the severe form with fatal outcome2-10. Differential diagnosis is often difficult and includes SFGR caused by Rickettsia felis, dengue, leptospiroses and meningococcemia, among others known diseases in Brazil. The classic red-spotted rash usually develops 3-5 days after the onset of other symptoms on the patient's extremities (ankles, feet, wrists, and hands) and spreads to the body. After six or more days of the illness, the rash can become petechial and can subsequently coalesce to form ecchymoses or gangrene. In Brazil, as well as other places of world, spotted fever cases without rash or with fleeting or atypical skin eruptions (evanescent, localized to a particular region of the body, papulovesicular or ulcerative lesions), have been confirmed. Although in some cases the absence of rash may be due to the prompt institution of therapy with doxycycline/tetracycline or chloramphenicol, in other confirmed cases, in which long delays in the diagnosis and treatment occurred, the characteristic rash does not develop or is not detected, particularly in black patients8-10.
The serological diagnosis, more specifically indirect immunofluorescence assay (IFA), is the most frequently used method for confirming spotted fever worldwide, but its use is limited during the first 10 days of disease and polymerase chain reaction assay (PCR) should be considered for the diagnosis at this acute onset of illness5,10.
Herein, the authors report a case of fatal BSF diagnosed at autopsy by molecular methods in a black man with absence of cutaneous lesions.
On November 25th 2006, a 32-year-old, previously healthy black man, sought medical attention by a primary care physician with complaints of high fever, headache, nausea, myalgia and asthenia. He was treated with oral amoxicillin, but his symptoms persisted. Two days later, he was admitted to hospital in Itambacuri County, in the State of Minas Gerais, Southeast Brazil, with the presumptive diagnostic of dengue fever. Examination showed fever to 38.8ºC, mild dehydration and hypotension. The laboratory findings showed a hematocrit of 47%, white blood cell count of 4,700/mm3, neutrophils 50%, a platelet count of 60,000/mm3, creatinine of 4.2mg/dl, ureia of 139mg/dl, and total bilirubin level of 6.2mg/dl. After symptomatic treatment, the patient developed neurological manifestations, lethargy, mental confusion, agitation and a generalized seizure. Empiric treatment with chloramphenicol was initiated, but the patient's condition worsened and he died from multiple organ failure 24h after admission. Although there was no history of tick bites or exposure to tick-infested habitats, the patient lived in a rural area where two other cases of unexplained deaths in young adults had been notified within the preceding months. An autopsy was performed and serum and tissue samples from various organs were analyzed at the Laboratory of Hantaviroses and Rickettsioses, Oswaldo Cruz Foundation.
Indirect immunofluorescence assays for immunoglobulin M (IgM) and IgG antibodies reactive to R. rickettsii (PanbioTM, Australia) were performed on serum and were nonreactive. DNA extraction from liver, heart and lung tissue autopsy samples was performed using the QIAamp DNA Blood Mini kit (QIAGEN®, Hilden, Germany), in accordance with the manufacturer's instructions. PCR assay was performed as described previously5. Segments of several rickettsial genes, including the 17kDa antigen gene [htrA], ompA, ompB and citrate synthase [gltA] were amplified from liver, heart and lung tissue DNA. The PCR products were purified using QIAquick PCR Purification Kit (QIAGEN) and sequenced using the ABI Prism 377 DNA Sequencer (Applied Biosystems, CA, USA). All sequences were edited with the BioEdit software, identified with the BLAST software (http://blast.ncbi.nlm.nih.gov/Blast.cgi), and the partial sequence ompA from the tissue samples generated in this study (GenBank accession nº FJ959382) showed 99% identity to the corresponding sequence of R. rickettsii ompA gene available at the GenBank.
The clinical severity of BSF, like RMSF, varies from mild to severe or fatal presentations1-10. Nonspecific clinical symptoms, such as fever, headache and muscle pain, occur in the first 10 days after the tick bite of the genus Amblyomma, particularly A. cajennense. The typical rash usually occurs on days 3 to 5 of the disease. In its early stages, this tick-borne disease can resemble many other infectious diseases, such as dengue and leptospirosis, which are endemic in Brazil, making diagnosis difficult, especially in patients with gastrointestinal and severe systemic manifestations with no presentation of a rash or a known history of tick bites2-5.
In the case reported here, a diagnosis of BSF was not considered due to the absence of cutaneous lesions. This probably made a correct diagnosis even more difficult. Although the rash may be completely absent or atypical in up to 15-20% of RMSF cases, spotless rickettsiosis caused by R. rickettsii in black patients has rarely been reported8,9. One review of 43 cases of Rocky Mountain spotless or almost spotless fever was published in 1992 and the authors demonstrated 61% of these patients had been men and two-thirds of them were black9.
The only serum sample collected on day 5 of disease was IFA negative for antibodies to SFGR. Indirect immunofluorescence assays remains the most commonly used serological technique for diagnosis; however, serological evidence of infection occurs no earlier than 7 to 10 days after the onset of illness8,10. Thus, the diagnosis must be based on clinical and epidemiological grounds, because the delay of specific treatment with doxycycline or chloramphenicol increases the risk of severe or fatal outcomes.
In the present case, death occurred five days following the onset of illness, an acute fulminant presentation. Although at least half of all deaths occur within 7 to 9 days of disease, accelerated clinical courses may occur and other variables, such as chronic alcoholism, cardiac problems and glucose-6-phosphate dehydrogenase deficiency (G6PD), associated with absence of early antibiotic treatment, can explain the severity of these cases10. None of the conditions previously mentioned were identified, except for delayed treatment, though G6PD deficiency is not routinely performed. PCR is a useful diagnostic method in the early phase of illness when antibodies are undetectable5,10. In this case report, ompA sequences by PCR amplification detected in tissue fragments of liver, heart and lung were sequenced and R. rickettsii was identified as the etiologic agent.
The present case illustrates well the diversity of clinical presentations of BSF and the difficulty of detecting the rash on dark-skinned inidividuals,emphasizingtheimportanceoftheearliestpossibleantibiotic empiric therapy in severe spotless fever, during the period of May to November, when peak Amblyomma reproductive activity is observed.
Finally, although the detection of antibodies against SFGR remains the best recognized and most used laboratory method to confirm BSF, PCR should be considered the gold standard early in the course of disease and an important diagnostic tool to help identify missed, unconfirmed, or unreported deaths which may be caused by R. rickettsii in Brazil.
The authors are grateful to Raphael Gomes, Aline Cristino Moura and Alexandro Guterres at the Laboratory of Hantaviruses and Rickettsioses, Instituto Oswaldo Cruz/FIOCRUZ, for their technical assistance.
1. Piza JT, Gomes LS, Meuer JR, Fleury JP, Castro O, Rodrigues C, et al. Le typho exanthémátique à São Paulo. CR Soc Biol 1931;106:1020-1022. [ Links ]
2. Lemos ER, Alvarenga FB, Cintra ML, Ramos MC, Paddock CD, Ferebee TL, et al. Spotted fever in Brazil: a seroepidemiological study and description of clinical cases in an endemic area in the state of São Paulo. Am J Trop Med Hyg 2001;65:329-334. [ Links ]
3. Angerami RN, Resende MR, Feltrin AF, Katz G, Nascimento EM, Stucchi RS, et al. Brazilian spotted fever: a case series from an endemic area in southeastern Brazil: clinical aspects. Ann N Y Acad Sci 2006;1078:252-254. [ Links ]
4. Rozental T, Eremeeva ME, Paddock CD, Zaki SR, Dasch GA, Lemos ER. Fatal case of Brazilian spotted fever confirmed by immunohistochemical staining and sequencing methods on fixed tissues. Ann N Y Acad Sci 2006;1078:257-259. [ Links ]
5. Lamas CC, Favacho ARM, Rozental T, Bóia MN, Kirsten AH, Guterres A, et al. Characterization of Rickettsia rickettsii in a case of fatal Brazilian spotted fever in the city of Rio de Janeiro, Brazil. Braz J Infect Dis 2008;12:149-151. [ Links ]
6. Sexton DJ, Muniz M, Corey GR, Breitschwerdt EB, Hegarty BC, Dumler S, et al. Brazilian spotted fever in Espirito Santo, Brazil: description of a focus of infection in a new endemic region. Am J Trop Med Hyg 1993;49:222-226 [ Links ]
7. Green WR, Walker DH, Cain BG. Fatal viscerotropic Rocky Mountain spotted fever. Report of a case diagnosed by immunofluorescence. Am J Med 1978;64:523-528. [ Links ]
8. Sexton DJ, Corey GR. Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin Infect Dis 1992;15:439-448. [ Links ]
9. Walker DH, Hawkins HK, Hudson P. Fulminant Rocky Mountain spotted fever: its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983;107:121-125. [ Links ]
10. Parola P, Labruna MB, Raoult D. Tick-borne rickettsioses in America: unanswered questions and emerging diseases. Curr Infect Dis Rep 2009;11:40-50. [ Links ]
Dra. Alexsandra Rodrigues de Mendonça Favacho
Lab. Hantaviroses e Rickettsioses/IOC/FIOCRUZ
Av. Brasil 4365, Pavilhão Hélio e Peggy Pereira
21040-900 Rio de Janeiro, RJ, Brasil
Phone: 55 21 2562-1897/1727; Fax: 55 21 2562-1897
Received in 09/08/2010
Accepted in 04/02/2011